On The Pen: The Weekly Dose 3/5/24

Send a text

This week Dave covers the latest in the Change Healthcare Hack, some interesting pubmed tirzepatide  data , and Oprah’s exit from the Weight Watchers board of directors.

Become a YouTube Community Member By Clicking Here:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

On The Pen Live Show (All Episodes In Order):
 https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM

For Those Facing GLP-1 Access Issues:
Https://www.FlexFinance.Care
Tell them “Dave sent you” 😉

Zepbound FB Group:
https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfP

SHOW LINKS
Change Healthcare Ransom Paid:
https://www.wired.com/story/alphv-change-healthcare-ransomware-payment/
Pubmed Asians vs. Non-Asians With DM2 Using Tirzepatide
https://pubmed.ncbi.nlm.nih.gov/38402331/
Oprah Leaving WW Board
https://www.thedailybeast.com/oprah-is-leaving-weightwatchers-after-revealing-weight-loss-drug-use
Dr. Michael Albert Interview:
https://youtu.be/nB9CXEsGNDc
The Big Shot Review
https://youtu.be/l-uyFOxqSYk

Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

🤝 Visit Our Sponsors!
OTPLinks.com

Decoding GLP-1 Book
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
Buy Here: https://amzn.to/3Dc66d4

MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro

BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

👉 My Amazon Affiliate Store:
https://www.amazon.com/shop/manonthemounjaroonthepen

WATCH MORE!
📺 We're Live M/W/F at 11 central: onthepen.tv

📲 Contact Me: dave@onthepen.com

Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.